sacituzumab govitecan
gilead sciences
[' sg ', 'breast']
presented by #hoperugo in #asco2022 in metastatic hr+her2~ metastatic #breastcancer showing pfs benefit from 4 m to 5.5 in sg compared to chemotherapy 
medical oncology, breast cancer maccabi health services, oncology real world research, international lecture